NPI: 1134186315 · JEFFERSONVILLE, IN 47130 · General Acute Care Hospital · NPI assigned 04/29/2006
Authorized official GAST, SHELLEY controls 20+ related entities in our dataset. Read more
| Authorized Official | GAST, SHELLEY (VP MANAGED CARE) |
| NPI Enumeration Date | 04/29/2006 |
Other providers sharing the same authorized official: GAST, SHELLEY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 58,185 | $889K |
| 2019 | 69,628 | $2.24M |
| 2020 | 53,175 | $2.47M |
| 2021 | 64,294 | $3.50M |
| 2022 | 68,738 | $4.10M |
| 2023 | 57,869 | $3.54M |
| 2024 | 46,983 | $2.88M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 37,044 | 29,413 | $4.50M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 30,590 | 25,070 | $3.72M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,139 | 20,953 | $2.83M |
| 71046 | Radiologic examination, chest; 2 views | 16,041 | 12,726 | $1.54M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 20,694 | 15,490 | $1.07M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 21,209 | 16,564 | $957K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,634 | 5,480 | $818K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,256 | 365 | $551K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5,751 | 4,588 | $463K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 923 | 741 | $303K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,997 | 2,847 | $283K |
| 71045 | Radiologic examination, chest; single view | 2,619 | 2,032 | $267K |
| 90837 | Psychotherapy, 53 minutes with patient | 3,370 | 1,357 | $239K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 12,534 | 1,764 | $202K |
| 80053 | Comprehensive metabolic panel | 41,147 | 31,470 | $199K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 52,574 | 39,524 | $186K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,222 | 4,061 | $161K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,356 | 2,094 | $133K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,231 | 1,951 | $122K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,100 | 863 | $114K |
| 97597 | 1,014 | 398 | $112K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,713 | 1,190 | $90K |
| 84484 | 13,767 | 9,310 | $81K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,733 | 4,573 | $80K |
| 62323 | 117 | 94 | $64K | |
| 83880 | 3,608 | 2,716 | $59K | |
| G0378 | Hospital observation service, per hour | 576 | 308 | $51K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,862 | 1,570 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,566 | 1,273 | $44K |
| 83690 | 14,514 | 11,558 | $40K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,023 | 6,913 | $34K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,884 | 1,665 | $33K |
| 81025 | 7,568 | 6,415 | $32K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 15 | 14 | $20K |
| 87400 | 3,860 | 2,678 | $19K | |
| 87430 | 2,680 | 2,291 | $18K | |
| 81001 | 11,844 | 9,470 | $17K | |
| 81003 | 13,088 | 10,315 | $14K | |
| 94761 | 426 | 348 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,198 | 2,495 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 105 | 77 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 423 | 331 | $6K |
| 76830 | Ultrasound, transvaginal | 26 | 25 | $6K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 26 | 25 | $5K |
| 36415 | Collection of venous blood by venipuncture | 3,520 | 2,367 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,909 | 1,629 | $5K |
| 87081 | 1,241 | 1,056 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 220 | 187 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 220 | 187 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 364 | 279 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | 27 | 25 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 51 | 38 | $3K |
| 80061 | Lipid panel | 310 | 244 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 199 | 143 | $2K |
| 82075 | 197 | 168 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14 | 13 | $1K |
| 85730 | 878 | 660 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 64 | 54 | $1K |
| 83735 | 408 | 321 | $1K | |
| 80361 | 38 | 12 | $983.37 | |
| 85610 | 996 | 748 | $904.76 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,905 | 2,578 | $863.59 |
| 85027 | 203 | 162 | $742.50 | |
| 76000 | 27 | 19 | $700.00 | |
| 82962 | 1,017 | 684 | $651.29 | |
| 84436 | 95 | 79 | $497.01 | |
| 87070 | 136 | 113 | $486.56 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,782 | 4,116 | $461.50 |
| 87150 | 12 | 12 | $422.13 | |
| 80076 | 78 | 65 | $402.33 | |
| A9270 | Non-covered item or service | 3,012 | 2,146 | $268.01 |
| 82948 | 538 | 417 | $261.51 | |
| 73630 | 15 | 12 | $244.05 | |
| 82550 | 45 | 40 | $211.48 | |
| 85379 | 48 | 39 | $209.28 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 13 | 12 | $199.51 |
| 90791 | Psychiatric diagnostic evaluation | 59 | 42 | $166.10 |
| 83970 | 22 | 14 | $159.29 | |
| 73610 | 18 | 12 | $126.08 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 32 | 26 | $119.81 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 475 | 409 | $112.41 |
| 84439 | 12 | 12 | $108.33 | |
| 84702 | 15 | 13 | $93.36 | |
| 87186 | 43 | 27 | $77.47 | |
| 87077 | 23 | 14 | $69.27 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 869 | 749 | $64.44 |
| 72110 | 17 | 14 | $63.32 | |
| 87210 | 13 | 12 | $28.20 | |
| 82570 | 23 | 15 | $19.98 | |
| 84100 | 23 | 15 | $18.27 | |
| 84156 | 23 | 15 | $14.14 | |
| 87205 | 15 | 12 | $5.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 730 | 595 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 185 | 161 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 321 | 259 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 15 | 13 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 106 | 88 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 96 | 77 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 57 | 50 | $0.00 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | 71 | 45 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 16 | 14 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 50 | 44 | $0.00 |
| A6260 | Wound cleansers, any type, any size | 17 | 15 | $0.00 |
| 80320 | 14 | 12 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 106 | 92 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 345 | 284 | $0.00 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 357 | 153 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 55 | 52 | $0.00 |